These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22760984)

  • 1. Nutritional status, genetic susceptibility, and insulin resistance--important precedents to atherosclerosis.
    McGillicuddy FC; Roche HM
    Mol Nutr Food Res; 2012 Jul; 56(7):1173-84. PubMed ID: 22760984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ; Chitturi S; Heydet D; Farrell GC
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
    Murdolo G; Smith U
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.
    Hamsten A; Eriksson P
    J Intern Med; 2008 May; 263(5):538-52. PubMed ID: 18410597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
    Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrigenomics in cardiovascular disease: implications for the future.
    Engler MB
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):190-5. PubMed ID: 20002344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nutritional transition and non-communicable diet-related chronic diseases in developing countries].
    Maire B; Lioret S; Gartner A; Delpeuch F
    Sante; 2002; 12(1):45-55. PubMed ID: 11943638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dietary therapy for prevention and treatment of atherosclerosis from the perspective of anti-inflammation].
    Tada N
    Nihon Rinsho; 2011 Jan; 69(1):110-8. PubMed ID: 21226270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic contributors toward increased risk for ischemic heart disease.
    Nordlie MA; Wold LE; Kloner RA
    J Mol Cell Cardiol; 2005 Oct; 39(4):667-79. PubMed ID: 16087188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphisms and susceptibility to coronary artery disease.
    Shah SH
    Pediatr Blood Cancer; 2007 Jun; 48(7):738-41. PubMed ID: 17262794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
    Reddy KJ; Singh M; Bangit JR; Batsell RR
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies beyond genome-wide association studies for atherosclerosis.
    Maouche S; Schunkert H
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):170-81. PubMed ID: 22258900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.